Notice of End of Production of ZOLL G3 Legacy Products

Notice of End of Production of ZOLL G3 Legacy Products

For almost two decades, the Powerheart G3 (9300x), G3 Plus (9390x), and G3 PRO (9300P) Automated External Defibrillators have served our global customers in providing first response defibrillation therapy to victims of sudden cardiac arrest.End of Production G3 Legacy CANADA Customer Letter FINAL

After careful consideration, we will be ending the production of these specific AED models on March 31, 2021, or sooner based on demand. We are providing this notice so that customers and business partners may begin planning ahead of our end of production for these specific AED models.

What does this mean?

• We are committed to supporting our G3, G3 Plus and G3 PRO customers with service and technical support. Each device listed above will include the standard limited
• Defibrillation pads, non-rechargeable batteries, carry cases, and select accessories will remain available for the duration of the warranty
• The G5 is not affected by the end of production announcement and remain a strong part of the Powerheart family of AEDs

The ZOLL Powerheart G5 AED with Intellisense™ CPR (ICPR) technology will continue to serve our global customers. As part of the ZOLL Medical family, the G5 AED joins the ZOLL AED Plus and ZOLL AED 3® as part of a broad portfolio of guideline-driven, real-time CPR Feedback AEDs. Together, these devices can help to ensure early defibrillation and high-quality CPR to victims of sudden cardiac arrest which can help save more lives.

Thank you for trusting the Powerheart G3, G3 Plus and G3 PRO series of products to serve as your first response AED. Please contact your authorized ZOLL distributor or ZOLL customer service at 866-442-1011 (905.629.5005) with questions regarding this notification, or to learn more about our CPR Feedback AEDs and services. We look forward to supporting our customers and distribution partners with the new portfolio of devices and our upcoming product releases.

For more information,  you can read the press release here.